Entry comments: Good news on the stock with backing from Bill Gates. Likelihood of its success long term is relatively high.

Exit comments: Increasing position on a dip that occurred despite good news, market realization on the stock's worth should hit later in the day. Added 150 overall priced at 12.9083 on 4/30/20. Stock was shorted and distorted off a Roth analyst downgrade, along with Citron research claims that it echos Theranos. Sold at a hefty loss thinking that INO would hold up around 12. Stop loss saved me from further losses after it dipped to 9.53 before bouncing.